The implications of APOBEC3-mediated C-to-U RNA editing for human disease

Commun Biol. 2024 May 4;7(1):529. doi: 10.1038/s42003-024-06239-w.

Abstract

Intra-organism biodiversity is thought to arise from epigenetic modification of constituent genes and post-translational modifications of translated proteins. Here, we show that post-transcriptional modifications, like RNA editing, may also contribute. RNA editing enzymes APOBEC3A and APOBEC3G catalyze the deamination of cytosine to uracil. RNAsee (RNA site editing evaluation) is a computational tool developed to predict the cytosines edited by these enzymes. We find that 4.5% of non-synonymous DNA single nucleotide polymorphisms that result in cytosine to uracil changes in RNA are probable sites for APOBEC3A/G RNA editing; the variant proteins created by such polymorphisms may also result from transient RNA editing. These polymorphisms are associated with over 20% of Medical Subject Headings across ten categories of disease, including nutritional and metabolic, neoplastic, cardiovascular, and nervous system diseases. Because RNA editing is transient and not organism-wide, future work is necessary to confirm the extent and effects of such editing in humans.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • APOBEC Deaminases*
  • APOBEC-3G Deaminase / genetics
  • APOBEC-3G Deaminase / metabolism
  • Cytidine Deaminase* / genetics
  • Cytidine Deaminase* / metabolism
  • Cytosine / metabolism
  • Cytosine Deaminase / genetics
  • Cytosine Deaminase / metabolism
  • Humans
  • Polymorphism, Single Nucleotide
  • Proteins / genetics
  • Proteins / metabolism
  • RNA Editing*
  • Uracil / metabolism

Substances

  • Cytidine Deaminase
  • APOBEC3A protein, human
  • Cytosine
  • APOBEC-3G Deaminase
  • Uracil
  • APOBEC3G protein, human
  • APOBEC3 proteins, human
  • Proteins
  • Cytosine Deaminase
  • APOBEC Deaminases